What Has Been the Growth of the Large Volume Parenteral (LVP) Market So Far?
The large volume parenteral (lvp) market has seen considerable growth due to a variety of factors.
•In recent times, the market size of large volume parenteral (LVP) has seen significant growth. It's projected to rise from $12.52 billion in 2024 to $13.57 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.3%.
Factors contributing to this growth during the historic period include the escalating prevalence of chronic illnesses, upsurge in the elderly population, increasing need for sterile pharmaceuticals, improvement of healthcare facilities, and the establishment of regulatory guidelines governing pharmaceuticals.
What Are the Future Growth Projections for the Large Volume Parenteral (LVP) Market?
The large volume parenteral (lvp) market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market size for large volume parenteral (LVP) is anticipated to witness a substantial growth, reaching $19.46 billion in 2029 with a compound annual growth rate (CAGR) of 9.4%.
The projected growth can be associated with the escalating demand for biologics and biosimilars, increasing healthcare expenditure, the broadening of pharmaceutical outsourcing, intensified emphasis on personalized medicine, and the globalization of pharmaceutical supply chains. Significant trends anticipated during the forecast period encompass technological enhancements in manufacturing processes, adoption of breakthrough technologies in pharmaceutical manufacturing, the implementation of single-use technologies, the creation of high-concentration formulations, and the proliferation of 3D printing applications in the pharmaceutical industry.
What Are The Core Factors Supporting Growth In The Large Volume Parenteral (LVP) Market?
The large-volume parenteral market's expansion appears likely to be boosted by the increasing prevalence of chronic diseases. Characterized as illnesses or conditions that typically persist for three months or more and may gradually deteriorate over time, the surge in chronic diseases is predominantly prompted by factors such as tobacco consumption, exposure to smoke, and inadequate nutrition. Patients with these conditions need a proper balance of essential nutrients to sustain their strength, and the parenteral method of administration enables the accurate delivery of pharmaceutical dosages as it goes directly into circulation, bypassing the digestive system. For example, data from the World Health Organization, a Switzerland-based agency of the United Nations, revealed in September 2023 that there had been 41 million deaths worldwide, accounting for 74% of all deaths caused by non-communicable diseases (NCDs) or chronic diseases in a year. Hence, the escalating prevalence of chronic diseases is a pivotal driver for the growth of the large-volume parenteral market.
What Are The Major Segments Within The Global Large Volume Parenteral (LVP) Market?
The large volume parenteral (LVP) market covered in this report is segmented –
1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP
2) By Volume: 100 ML - 250 ML, 250 ML - 500 ML, 500 ML - 1000 ML, 1000 ML -2000 ML, 2000 And More
3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion
4) By End-User: Hospital, Medical Centers, Other End Users
Subsegments:
1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags
2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags
3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles
Pre-Book The Large Volume Parenteral (LVP) Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Trends Are Expected To Transform The Large Volume Parenteral (LVP) Market?
The large-volume parenteral market is seeing an increasing emphasis on product innovation. Key players in the market are focusing on the development of novel products to fortify their market standing. As an example, SGD Pharma SA, a French company specializing in the production of molded and tubular glass for the primary packaging of pharmaceuticals, introduced sterile, 100-ml type I molded glass vials fit for aseptic filling and finishing of parenteral drugs in March 2022. These prevent the occurrence of scratches on the vial, aid in visual assessments of the filled vial and reduce the chance of rejection during quality control.
Who Are the Key Players in the Large Volume Parenteral (LVP) Market?
Major companies operating in the large volume parenteral (LVP) market include:
• Pfizer Inc.
• Fresenius Kabi AG
• Abbott Laboratories Inc.
• Becton Dickinson and Company
• Otsuka Holdings Co Ltd.
• Baxter International Inc.
• B Braun Melsungen AG
• Grifols SA
• Cipla Limited
• ICU Medical Inc.
• Biocon Limited
• Sichuan Kelun Pharmaceutical Co. Ltd.
• Alembic Pharmaceuticals Limited
• Cadila Healthcare Ltd.
• Gland Pharma Limited
• Akums Drugs & Pharmaceuticals Ltd.
• Beximco Pharmaceutical Ltd.
• Nelson Laboratories LLC
• Taj Pharmaceuticals Limited
• Albert David Ltd.
• Amanta Healthcare Ltd.
• Unique Pharmaceutical Laboratories Ltd.
• Ahlcon Parenterals India Ltd
• Parenteral Drugs Limited
• Abaris Healthcare Pvt. Ltd.
• BML Parenteral Drugs
• Denis Chem Lab Ltd
• Pentagon Labs Ltd.
• DJ Labs Pvt Ltd.
• Higgs Healthcare.
What Is The Most Dominant Region In The Large Volume Parenteral (LVP) Market?
North America was the largest region in the large volume parenteral (LVP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (LVP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
